Elevated Pentraxin 3 in Patients with Systemic Sclerosis: Associations with Vascular Manifestations and Defective Vasculogenesis.

被引：0
|
作者：
Shirai, Yuichiro [1 ]
Okazaki, Yuka [1 ]
Inoue, Yumiko [1 ]
Tamura, Yuichi [1 ]
Yasuoka, Hidekata [1 ]
Takeuchi, Tsutomu [1 ]
Kuwana, Masataka [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
746
引用
收藏
页码：S327 / S328
页数：2
相关论文
共 50 条
  • [41] An elevated circulating level of periostin in patients with systemic sclerosis: Associations with functional impairment in various affected organs
    Yamaguchi, Y.
    Shirai, Y.
    Ono, J.
    Kawaguchi, Y.
    Izuhara, K.
    Kuwana, M.
    Aihara, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S62 - S62
  • [42] Elevated whole blood chemiluminescence in patients with systemic sclerosis
    Luczynska, A
    Szkudlarek, U
    Dziankowska-Bartkowiak, B
    Waszczykowska, E
    Kasielski, M
    Jozefowicz-Okonkwo, G
    Nowak, D
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (02) : 173 - 179
  • [43] Elevated exhalation of hydrogen peroxide in patients with systemic sclerosis
    Luczyñska, M
    Szkudlarek, U
    Dziankowska-Bartkowiak, B
    Waszczykowska, E
    Kasielski, M
    Sysa-Jèdrzejowska, A
    Nowak, D
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (03) : 274 - 279
  • [44] EVIDENCE OF TYPE I INTERFERON ACTIVATION DURING VASCULAR MANIFESTATIONS OF SYSTEMIC SCLEROSIS
    Di Donato, S.
    Hughes, M.
    Abignano, G.
    Lettieri, G.
    Ross, R.
    De Lorenzis, E.
    O'Connor, P.
    Kubassova, O.
    Del Galdo, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1200 - 1200
  • [45] EVIDENCE OF TYPE I INTERFERON ACTIVATION DURING VASCULAR MANIFESTATIONS OF SYSTEMIC SCLEROSIS
    Di Donato, Stefano
    Hughes, Michael
    Geloshi, Klaudian
    De Lorenzis, Enrico
    Kakkar, Vishal
    Ross, Rebecca
    O'Connor, Philip
    Kubassova, Olga
    Del Galdo, Francesco
    RHEUMATOLOGY, 2023, 62
  • [46] Associations of autoantibodies and clinical profile of the patients with systemic sclerosis
    Mahmud, Shahin
    Choudhury, Minhaj R.
    Bandhan, Iftekhar H.
    Islam, Md. Sahidul
    Abu Shahin, Md.
    Haq, Syed A.
    Zaman, Mohammad M.
    RHEUMATOLOGY & AUTOIMMUNITY, 2022, 2 (03): : 141 - 149
  • [47] Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
    Liu, Siguan
    Qu, Xin
    Liu, Feng
    Wang, Chunting
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [48] The Relationship Between Vascular Biomarkers and Disease Characteristics in Systemic Sclerosis: Elevated MCP-1 Is Associated with Predominantly Fibrotic Manifestations.
    Yalcinkaya, Yasemin
    Cinar, Suzan
    Kamali, Sevil
    Ocal, Lale
    Deniz, Gunnur
    Inanc, Murat
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S753 - S754
  • [49] Clinical, electro and telecardiographic manifestations in a series of patients with systemic sclerosis
    Lopez Mantecon, Ana Marta
    Casadesns Castillo, Alberto Carlos
    Toledo Quesada, Antonio Guillermo
    Pozo Abreu, Silvia Maria
    Mederos Castellanos, Ailyn
    Chuairey Llerena, Carmen Delia
    REVISTA CUBANA DE REUMATOLOGIA, 2022, 24 (01):
  • [50] CLINICAL MANIFESTATIONS OF PERSISTENT ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC SCLEROSIS PATIENTS
    Myriam, S.
    Sobanski, V.
    Lemaire, A.
    Giovannelli, J.
    Hachulla, E.
    Lopez, B.
    Lambert, M.
    Hatron, P. -Y.
    Dubucquoi, S.
    Launay, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 761 - 761
12345